Related Experiment Videos
Secondary membranous nephropathy--one center experience
Zuzana Rihova1, Eva Honsova, Miroslav Merta
1Nephrology Unit, 1st Medical Faculty, Charles University, Prague, Czech Republic. zrihova@centrum.cz
Renal Failure
|August 3, 2005
Summary
Identifying secondary membranous nephropathy (MN) causes is crucial for treatment. Prompt diagnosis and management of drug-induced and autoimmune MN lead to better patient outcomes.
Area of Science:
- Nephrology
- Immunology
- Oncology
Background:
- Secondary membranous nephropathy (MN) is frequently associated with autoimmune diseases, infections, neoplasms, and certain medications.
- Understanding the specific triggers of secondary MN is vital for effective patient management.
Purpose of the Study:
- To investigate the presenting characteristics and outcomes of patients diagnosed with secondary membranous nephropathy.
- To analyze the impact of underlying causes on the prognosis of secondary MN.
Main Methods:
- Retrospective analysis of 129 patients diagnosed with membranous nephropathy (MN) between 1991 and 2002.
- Review of renal biopsies and patient data to identify underlying causes and treatment responses.
Main Results:
- Forty patients (31%) had identifiable secondary causes, with drug-induced (45%) and autoimmune diseases (27.5%) being most common.
- Patients with drug-induced MN achieved remission upon drug withdrawal; those with autoimmune MN responded well to immunosuppression.
- Outcomes were significantly poorer for patients with secondary MN associated with neoplasms.
Conclusions:
- Early and comprehensive identification of secondary causes in membranous nephropathy (MN) is essential.
- Prognostic and therapeutic strategies should be tailored based on the identified cause, particularly for drug-induced and autoimmune MN.